Tarbox Family Office’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.49M | Sell |
43,624
-683
| -2% | -$152K | 1.54% | 17 |
|
|
2025
Q4 | $10.1M | Sell |
44,307
-83
| -0.2% | -$18.9K | 1.63% | 14 |
|
|
2025
Q3 | $10.3M | Buy |
44,390
+1
| +0% | +$204 | 1.51% | 14 |
|
|
2025
Q2 | $8.24M | Hold |
44,389
| – | – | 1.24% | 15 |
|
|
2025
Q1 | $9.3M | Sell |
44,389
-10
| -0% | -$1.94K | 1.55% | 14 |
|
|
2024
Q4 | $7.89M | Buy |
44,399
+10
| +0% | +$1.84K | 1.3% | 16 |
|
|
2024
Q3 | $8.77M | Buy |
44,389
+750
| +2% | +$140K | 1.44% | 14 |
|
|
2024
Q2 | $7.48M | Hold |
43,639
| – | – | 1.32% | 14 |
|
|
2024
Q1 | $7.95M | Buy |
43,639
+4,200
| +11% | +$724K | 1.4% | 14 |
|
|
2023
Q4 | $6.11M | Sell |
39,439
-5,832
| -13% | -$850K | 1.19% | 16 |
|
|
2023
Q3 | $6.75M | Buy |
45,271
+33
| +0.1% | +$4.84K | 1.4% | 16 |
|
|
2023
Q2 | $6.09M | Hold |
45,238
| – | – | 1.19% | 15 |
|
|
2023
Q1 | $7.21M | Hold |
45,238
| – | – | 1.46% | 13 |
|
|
2022
Q4 | $7.31M | Buy |
45,238
+5,794
| +15% | +$888K | 1.6% | 13 |
|
|
2022
Q3 | $6.04M | Sell |
39,444
-5,880
| -13% | -$844K | 1.43% | 12 |
|
|
2022
Q2 | $6.94M | Buy |
45,324
+5,880
| +15% | +$898K | 1.56% | 12 |
|
|
2022
Q1 | $6.39M | Sell |
39,444
-297
| -0.7% | -$43.1K | 1.3% | 11 |
|
|
2021
Q4 | $5.38M | Buy |
39,741
+91
| +0.2% | +$10.7K | 0.93% | 14 |
|
|
2021
Q3 | $4.28M | Buy |
39,650
+14
| +0% | +$1.6K | 0.78% | 14 |
|
|
2021
Q2 | $4.46M | Buy |
39,636
+8
| +0% | +$901 | 0.8% | 14 |
|
|
2021
Q1 | $4.29M | Sell |
39,628
-2,000
| -5% | -$214K | 0.84% | 14 |
|
|
2020
Q4 | $4.46M | Sell |
41,628
-524
| -1% | -$50.4K | 0.93% | 14 |
|
|
2020
Q3 | $3.69M | Buy |
42,152
+25
| +0.1% | +$2.35K | 0.9% | 15 |
|
|
2020
Q2 | $4.14M | Buy |
42,127
+2,421
| +6% | +$213K | 1.07% | 14 |
|
|
2020
Q1 | $3.02M | Sell |
39,706
-329
| -0.8% | -$28K | 0.98% | 14 |
|
|
2019
Q4 | $3.54M | Sell |
40,035
-2
| -0% | -$166 | 0.97% | 13 |
|
|
2019
Q3 | $3.03M | Sell |
40,037
-58
| -0.1% | -$3.98K | 0.92% | 15 |
|
|
2019
Q2 | $2.92M | Sell |
40,095
-767
| -2% | -$60.3K | 0.91% | 15 |
|
|
2019
Q1 | $3.29M | Sell |
40,862
-10
| -0% | -$818 | 1.2% | 13 |
|
|
2018
Q4 | $3.77M | Sell |
40,872
-1
| -0% | -$88 | 1.56% | 10 |
|
|
2018
Q3 | $3.87M | Sell |
40,873
-5,971
| -13% | -$566K | 1.4% | 10 |
|
|
2018
Q2 | $4.34M | Sell |
46,844
-937
| -2% | -$91.5K | 1.67% | 10 |
|
|
2018
Q1 | $4.52M | Sell |
47,781
-7,066
| -13% | -$776K | 1.75% | 9 |
|
|
2017
Q4 | $5.3M | Buy |
54,847
+624
| +1% | +$58.8K | 2.1% | 9 |
|
|
2017
Q3 | $4.82M | Sell |
54,223
-1,452
| -3% | -$111K | 2.11% | 8 |
|
|
2017
Q2 | $4.04M | Buy |
55,675
+2,000
| +4% | +$134K | 1.99% | 9 |
|
|
2017
Q1 | $3.5M | Hold |
53,675
| – | – | 1.81% | 9 |
|
|
2016
Q4 | $3.36M | Hold |
53,675
| – | – | 1.93% | 9 |
|
|
2016
Q3 | $3.38M | Hold |
53,675
| – | – | 2.18% | 10 |
|
|
2016
Q2 | $3.32M | Hold |
53,675
| – | – | 2.38% | 10 |
|
|
2016
Q1 | $3.07M | Buy |
53,675
+22
| +0% | +$1.23K | 2.32% | 11 |
|
|
2015
Q4 | $3.18M | Buy |
53,653
+19
| +0% | +$1.09K | 2.58% | 10 |
|
|
2015
Q3 | $2.92M | Buy |
53,634
+113
| +0.2% | +$7.36K | 2.67% | 8 |
|
|
2015
Q2 | $3.6M | Hold |
53,521
| – | – | 3.12% | 7 |
|
|
2015
Q1 | $3.13M | Hold |
53,521
| – | – | 2.75% | 10 |
|
|
2014
Q4 | $3.5M | Sell |
53,521
-52,045
| -49% | -$3.28M | 3.24% | 11 |
|
|
2014
Q3 | $6.1M | Buy |
105,566
+41
| +0% | +$2.28K | 5.5% | 8 |
|
|
2014
Q2 | $5.96M | Sell |
105,525
-764
| -0.7% | -$40.1K | 5.31% | 8 |
|
|
2014
Q1 | $5.41M | Buy |
106,289
+2,662
| +3% | +$135K | 4.82% | 8 |
|
|
2013
Q4 | $5.45M | Buy |
+103,627
| New | +$5.09M | 4.55% | 8 |
|
Other funds holding ABBV
VCM
VPM
Tarbox Family Office's ABBV Position: Q1 2026 in Review
Tarbox Family Office reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $152K and leaving 43,624 shares worth $9.49M. The position accounts for 1.54% of the portfolio, ranked #17.
Tarbox Family Office first reported a position in ABBV in Q4 2013 and has held it in 50 quarters since. The position peaked at $10.3M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Tarbox Family Office held 43,624 shares of AbbVie worth $9.49M as of Q1 2026.
- Tarbox Family Office sold 683 AbbVie shares in Q1 2026, an estimated $152K.
- AbbVie made up 1.54% of Tarbox Family Office's portfolio in Q1 2026, its #17 holding.
- Tarbox Family Office first reported a position in AbbVie in Q4 2013 and has held it in 50 quarters since.
- Tarbox Family Office's AbbVie position peaked at $10.3M in Q3 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Tarbox Family Office's 13F filing for Q1 2026, filed 24 Apr 2026.